John Nixon

3.9k total citations
51 papers, 3.2k citations indexed

About

John Nixon is a scholar working on Molecular Biology, General Health Professions and Economics and Econometrics. According to data from OpenAlex, John Nixon has authored 51 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in General Health Professions and 14 papers in Economics and Econometrics. Recurrent topics in John Nixon's work include Protein Kinase Regulation and GTPase Signaling (12 papers), Global Health Care Issues (10 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). John Nixon is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (12 papers), Global Health Care Issues (10 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). John Nixon collaborates with scholars based in United Kingdom, France and United States. John Nixon's co-authors include Sandra E. Wilkinson, Philippe Ulmann, Peter J. Parker, Christopher H. Hill, Geoffrey Lawton, Peter D. Davis, Elizabeth Keech, J. Wadsworth, Michael Drummond and D. Bradshaw and has published in prestigious journals such as Journal of Molecular Biology, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

John Nixon

51 papers receiving 3.1k citations

Peers

Countries citing papers authored by John Nixon

Since Specialization

Citations

This map shows the geographic impact of John Nixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Nixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Nixon more than expected).

Fields of papers citing papers by John Nixon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Nixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Nixon. The network helps show where John Nixon may publish in the future.

Co-authorship network of co-authors of John Nixon

This figure shows the co-authorship network connecting the top 25 collaborators of John Nixon. A scholar is included among the top collaborators of John Nixon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Nixon. John Nixon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing equity in health care through the national health insurance schemes of Nigeria and Ghana: a review-based comparative analysis 2013 ·International Journal for Equity in Health ·Isaac Odeyemi, John Nixon	112
2	Guidelines for completing the EURONHEED transferability information checklists 2008 ·The European Journal of Health Economics ·John Nixon, Stephen Rice, Michael Drummond, (unknown), Philippe Ulmann, Gérard de Pouvourville	33
3	Systematic Review of the (Cost-)effectiveness of Spinal Cord Stimulation for People With Failed Back Surgery Syndrome 2008 ·Clinical Journal of Pain ·Małgorzata M Bała, R.P. Riemsma, John Nixon, Jos Kleijnen	74
4	The relationship between health care expenditure and health outcomes 2006 ·The European Journal of Health Economics ·John Nixon, Philippe Ulmann	282
5	The Diffusion of Health Economics Knowledge in Europe 2005 ·PharmacoEconomics ·Gérard de Pouvourville, Philippe Ulmann, John Nixon, (unknown), Julie Glanville, Michael Drummond	18
6	Can economic evaluations be made more transferable? 2005 ·The European Journal of Health Economics ·(unknown), John Nixon, Michael Drummond, Philippe Ulmann, Stephen Rice, Gérard de Pouvourville	71
7	The European Network of Health Economic Evaluation Databases (EURO�NHEED) Project 2004 ·The European Journal of Health Economics ·John Nixon, Philippe Ulmann, Julie Glanville, (unknown), Michael Drummond, (unknown)	8
8	The usefulness of the NHS Economic Evaluation Database to researchers undertaking technology assessment reviews 2004 ·International Journal of Technology Assessment in Health Care ·John Nixon, Steven Duffy, Nigel Armstrong, Dawn Craig, Julie Glanville, (unknown), Michael Drummond, Jos Kleijnen	5
9	Re: Hutton J, Brown R. Use of economic evaluation in decision-making: what needs to change? (Editorial) Value Health 2002;5:65-6. 2002 ·PubMed ·Christiane Hoffmann, Boyka Stoykova, John Nixon, Julie Glanville, Kate Misso, Michael Drummond	101
10	Using economic evidence to support decision making: a case study of assertive community treatment within the UK National Service Framework for Mental Health. 2002 ·PubMed ·John Nixon, (unknown), Julie Glanville, Miranda Mugford, Michael Drummond	13
11	The U.K. NHS ECONOMIC EVALUATION DATABASE 2000 ·International Journal of Technology Assessment in Health Care ·John Nixon, Boyka Stoykova, Julie Glanville, (unknown), Michael Drummond, Jos Kleijnen	38
12	How does the UK NHS compare with European standards? A review of EU health care systems using hierarchical cluster analysis 2000 ·RePEc: Research Papers in Economics ·John Nixon	2
13	Metalloproteinases as Targets for Anti-Inflammatory Drugs 1999 ·Birkhäuser Basel eBooks ·K M K Bottomley, D. Bradshaw, John Nixon	38
14	T-cell signal transduction and the role of protein kinase C 1998 ·Cellular and Molecular Life Sciences ·Sandra E. Wilkinson, John Nixon	20
15	Ro 32‐3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo 1997 ·British Journal of Pharmacology ·E. J. Lewis, Joshua D. Bishop, K M K Bottomley, D. Bradshaw, Michael Brewster, Michael J. Broadhurst, Paul A. Brown, (unknown), Lucy H. Elliott, (unknown), William H. Johnson, John Nixon, Felicity R. A. J. Rose, Blaine M. Sutton, Kevin L. Wilson	100
16	PKC Inhibitors in the Therapy of Autoimmune Diseases 1996 ·Current Pharmaceutical Design ·Sandra E. Wilkinson, John Nixon	3
17	A novel conformationally restricted protein kinase C inhibitor, Ro 31‐8425, inhibits human neutrophil superoxide generation by soluble, particulate and post‐receptor stimuli 1991 ·FEBS Letters ·(unknown), M.Maureen Dale, Peter D. Davis, Lucy H. Elliott, Christopher H. Hill, (unknown), Geoffrey Lawton, Breda M. Twomey, J. Wadsworth, Sandra E. Wilkinson, John Nixon	52
18	The effect of new potent selective inhibitors of protein kinase C on the neutrophil respiratory burst 1990 ·Biochemical and Biophysical Research Communications ·Breda M. Twomey, (unknown), John Nixon, A. D. Sedgwick, Sandra E. Wilkinson, M.Maureen Dale	71
19	1H-NMR and protection studies of interactions between ligands and bovine pancreatic phospholipase A2 1989 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Michael P. Williamson, Peter D. Davis, Michael J. Broadhurst, John Nixon	2
20	Potent selective inhibitors of protein kinase C 1989 ·FEBS Letters ·Peter D. Davis, Christopher H. Hill, Elizabeth Keech, Geoffrey Lawton, John Nixon, (unknown), J. Wadsworth, D. Westmacott, Sandra E. Wilkinson	439

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact